EntryPoint Capital’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,706
Closed -$114K 836
2025
Q1
$114K Buy
15,706
+4,232
+37% +$33.2K 0.05% 609
2024
Q4
$92K Buy
+11,474
New +$99.5K 0.04% 673
2024
Q3
Sell
-6,874
Closed -$45K 1174
2024
Q2
$45K Buy
+6,874
New +$51.8K 0.07% 575

Other funds holding VMD

EntryPoint Capital's VMD Position: Q2 2025 in Review

EntryPoint Capital sold out of Viemed Healthcare (VMD) in Q2 2025, closing a stake of 15,706 shares — an estimated $114K sold.

EntryPoint Capital first reported a position in VMD in Q2 2024 and held it in 3 quarters. The position peaked at $114K in Q1 2025. 127 funds tracked by Wall St. Rank hold VMD as of Q2 2025.

  • EntryPoint Capital reported no remaining Viemed Healthcare position as of Q2 2025 after selling out during the quarter.
  • EntryPoint Capital sold 15,706 Viemed Healthcare shares in Q2 2025, an estimated $114K.
  • EntryPoint Capital first reported a position in Viemed Healthcare in Q2 2024 and held it in 3 quarters.
  • EntryPoint Capital's Viemed Healthcare position peaked at $114K in Q1 2025.
  • 127 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2025.

Based on EntryPoint Capital's 13F filing for Q2 2025, filed 11 Aug 2025.